Placental transfer of lopinavir/ritonavir in the ex vivo human cotyledon perfusion model
- 1 July 2006
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 195 (1) , 296-301
- https://doi.org/10.1016/j.ajog.2006.01.017
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Increased Expression of MDR1 mRNAs and P-glycoprotein in Placentas from HIV-1 Infected WomenPlacenta, 2005
- Differential Bidirectional Transfer of Indinavir in the Isolated Perfused Human PlacentaAntimicrobial Agents and Chemotherapy, 2005
- P-glycoprotein expression of the human placenta during pregnancyPlacenta, 2005
- Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virusAmerican Journal of Obstetrics and Gynecology, 2004
- Maternal toxicity and pregnancy complications in human immunodeficiency virus–infected women receiving antiretroviral therapy: PACTG 316American Journal of Obstetrics and Gynecology, 2004
- Concentrations of protease inhibitors in cord blood after in utero exposureThe Pediatric Infectious Disease Journal, 2002
- Protease Inhibitors and Decreased Birth Weight in HIV-Infected Pregnant Women With Impaired Glucose ToleranceJournal of Perinatology, 2002
- Antiretroviral Therapy during Pregnancy and the Risk of an Adverse OutcomeNew England Journal of Medicine, 2002
- Pregnancy and HIV infection: a European consensus on managementAIDS, 2002
- Combination antiretroviral therapy and duration of pregnancyAIDS, 2000